Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Multi-Center, Multi-National, Open-Label, Active Comparator Study to Evaluate the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00943111
Desconocido
ClinicalTrials.gov
The Impact of the Covid-19 Pandemic on the Mental Health of Workers in Health Services: The Covid-19 HEalth caRe wOrkErS (HEROES) Study
OBSERVATIONAL
Inicio: 26 de abr de 2020
ID: NCT04352634
Completado
ClinicalTrials.gov
Development of a Non-invasive Diagnosis Tool for the Analysis of the Microbiota to Improve Reproductive Outcomes in Infertile Patients.
OBSERVATIONAL
Inicio: 4 de ago de 2017
ID: NCT03330444
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril Combination Therapy Compared to Enalapril Monotherapy, on Morbidity and Mortality in Patients With Chronic Heart Failure (NYHA Class II - IV). The Study is Also Known as Aliskiren Trial of Minimizing OutcomeS in Patients With HEart Failure (ATMOSPHERE).
INTERVENTIONAL
Inicio: 1 de mar de 2009
ID: NCT00853658
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase IIIb Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis
INTERVENTIONAL
Inicio: 26 de nov de 2020
ID: NCT04544436
Completado
ClinicalTrials.gov
Prospective, Multicenter, Single Arm Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device
OBSERVATIONAL
Inicio: 1 de dic de 2015
ID: NCT02600364
Completado
Fase 3
ClinicalTrials.gov
An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
INTERVENTIONAL
Inicio: 7 de abr de 2014
ID: NCT02079246
Completado
ClinicalTrials.gov
Study Assessing Cognitive Performance Plus Physical Activity in Patients With Relapsing-Remitting MS Under Treatment With Betaferon®
OBSERVATIONAL
Inicio: 30 de abr de 2012
ID: NCT01491100
Completado
ClinicalTrials.gov
The Multiple Sclerosis Functional Composite (MSFC) in the Follow-up of MS Patients: Correlation With the Expanded Disability Status Scale (EDSS) Among Different Clinical Forms in Argentina
OBSERVATIONAL
Inicio: 1 de ago de 2008
ID: NCT01080014
Completado
Fase 3
ClinicalTrials.gov
A Phase 3b, Open-Label, Randomized, Multicenter Study to Assess the Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants
INTERVENTIONAL
Inicio: 5 de jun de 2014
ID: NCT02106390
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study to Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and Major Adverse Kidney Events in Participants With Body Mass Index ≥27 kg/m2 and Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease
INTERVENTIONAL
Inicio: 30 de abr de 2024
ID: NCT06383390
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease
INTERVENTIONAL
Inicio: 22 de ene de 2021
ID: NCT04592874
Completado
Fase 1
ClinicalTrials.gov
Comparative Pharmacokinetic and Pharmacodynamic Study Between 2 Agalsidase Beta Formulations at a Single Dose of 1 mg/kg of Agalsidase (Biosidus) and Fabrazyme (Sanofi Genzyme) as Intravenous Infusion in Male Healthy Volunteers
INTERVENTIONAL
Inicio: 23 de oct de 2021
ID: NCT05343715
Reclutando
ClinicalTrials.gov
Latin American Lifestyle Intervention Initiative to Reduce the Risk and Prevent Cognitive Impairment.
INTERVENTIONAL
Inicio: 1 de sept de 2021
ID: NCT06492967
Completado
Fase 4
ClinicalTrials.gov
A 12-month Prospective, Randomized, Interventional, Global, Multi-center, Active-controlled Study Comparing Sustained Benefit of Two Treatment Paradigms (AMG334 qm vs. Oral Prophylactics) in Adult Episodic Migraine Patients
INTERVENTIONAL
Inicio: 15 de may de 2019
ID: NCT03927144
Terminado
Fase 3
ClinicalTrials.gov
Multinational, Randomized, Double-Blind, Double-Dummy, Comparative Study to Evaluate the Efficacy and Safety of 5 Days Telithromycin 25mg/kg od Versus 5 Days Azithromycin 10 mg/kg od Followed by 5 mg/kg od for 4 Days, in Children With Acute Otitis Media
INTERVENTIONAL
Inicio: 1 de ene de 2006
ID: NCT00315003
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate the Efficacy and Safety of Ocrelizumab in Comparison to Interferon Beta-1a (Rebif) in Patients With Relapsing Multiple Sclerosis
INTERVENTIONAL
Inicio: 20 de sept de 2011
ID: NCT01412333
Completado
ClinicalTrials.gov
Improving Reading at Scale: Evidence for Structured Literacy Instruction in Argentina's Primary Schools
INTERVENTIONAL
Inicio: 1 de may de 2022
ID: NCT07451262
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-Blind, Randomized Conversion to Monotherapy Comparison of Two Doses of Lamotrigine for the Treatment of Partial Seizures
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00355082
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
INTERVENTIONAL
Inicio: 18 de mar de 2025
ID: NCT07032662
Anterior
1
...
14
15
16
...
434
Siguiente
Filtros